At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to ...

Novartis Pharmaceuticals on Thursday announced plans to build a facility in Morrisville.

With the addition of the new site, Novartis will operate five facilities across three locations in North Carolina.

The generic pharmaceuticals contract manufacturing market offers opportunities through rising demand for biosimilars, ...

Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...

It could also be a short-term tailwind for some energy producers.

The site is the final of seven planned facilities that Novartis committed to building as part of a $23 billion investment in U.S. manufacturing, which it announced last year. The ...

A batch of a common antidepressant has been recalled in the UK because of a manufacturing error. The manufacturer Amarox is ...

Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...

A precautionary recall of a common antidepressant medication has been issued today, April 28, due to a manufacturing error.

The UK's drug watchdog has recalled the affected antidepressant after a patient found the wrong medication in a pack ...

The service "is exploring how the emerging alternative-protein sector can help meet several objectives, including enhancing ...